{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:22:48Z","timestamp":1794565368354,"version":"4.9.1"},"reference-count":164,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2015\/19\/B\/NZ7\/02270"],"award-info":[{"award-number":["2015\/19\/B\/NZ7\/02270"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014269","name":"Uniwersytet Medyczny w Bia\u0142ymstoku","doi-asserted-by":"publisher","award":["N\/ST\/MN\/17\/001\/2213"],"award-info":[{"award-number":["N\/ST\/MN\/17\/001\/2213"]}],"id":[{"id":"10.13039\/501100014269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014269","name":"Uniwersytet Medyczny w Bia\u0142ymstoku","doi-asserted-by":"publisher","award":["N\/ST\/ZB\/18\/005\/2213"],"award-info":[{"award-number":["N\/ST\/ZB\/18\/005\/2213"]}],"id":[{"id":"10.13039\/501100014269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cannabidiol (CBD) is a non-intoxicating and generally well-tolerated constituent of cannabis which exhibits potential beneficial properties in a wide range of diseases, including cardiovascular disorders. Due to its complex mechanism of action, CBD may affect the cardiovascular system in different ways. Thus, we reviewed the influence of CBD on this system in health and disease to determine the potential risk of cardiovascular side effects during CBD use for medical and wellness purposes and to elucidate its therapeutic potential in cardiovascular diseases. Administration of CBD to healthy volunteers or animals usually does not markedly affect hemodynamic parameters. Although CBD has been found to exhibit vasodilatory and antioxidant properties in hypertension, it has not affected blood pressure in hypertensive animals. Hypotensive action of CBD has been mainly revealed under stress conditions. Many positive effects of CBD have been observed in experimental models of heart diseases (myocardial infarction, cardiomyopathy, myocarditis), stroke, neonatal hypoxic ischemic encephalopathy, sepsis-related encephalitis, cardiovascular complications of diabetes, and ischemia\/reperfusion injures of liver and kidneys. In these pathological conditions CBD decreased organ damage and dysfunction, oxidative and nitrative stress, inflammatory processes and apoptosis, among others. Nevertheless, further clinical research is needed to recommend the use of CBD in the treatment of cardiovascular diseases.<\/jats:p>","DOI":"10.3390\/ijms21186740","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T09:04:53Z","timestamp":1600074293000},"page":"6740","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":145,"title":["The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease"],"prefix":"10.3390","volume":"21","author":[{"given":"Aleksandra","family":"Kicman","sequence":"first","affiliation":[{"name":"Department of Experimental Physiology and Pathophysiology, Medical University of Bia\u0142ystok, 15-222 Bia\u0142ystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5823-0269","authenticated-orcid":false,"given":"Marek","family":"Toczek","sequence":"additional","affiliation":[{"name":"Department of Experimental Physiology and Pathophysiology, Medical University of Bia\u0142ystok, 15-222 Bia\u0142ystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,14]]},"reference":[{"key":"ref_1","first-page":"1","article-title":"Phytochemistry of Cannabis sativa. L.","volume":"103","author":"ElSohly","year":"2017","journal-title":"Prog. Chem. Org. Nat. Prod."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.siny.2019.02.001","article-title":"Cannabis: An ancient friend or foe? What works and doesn\u2019t work","volume":"24","author":"Henschke","year":"2019","journal-title":"Semin. Fetal. Neonatal. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fpls.2016.00019","article-title":"The Plant of the Thousand and One Molecules","volume":"7","author":"Andre","year":"2016","journal-title":"Front. Plant. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Gon\u00e7alves, J., Rosado, T., Soares, S., Sim\u00e3o, A.Y., Caramelo, D., Lu\u00eds, \u00c2., Fern\u00e1ndez, N., Barroso, M., Gallardo, E., and Duarte, A.P. (2019). Cannabis and Its Secondary Metabolites: Their Use as Therapeutic Drugs, Toxicological Aspects, and Analytical Determination. Medicines, 6.","DOI":"10.3390\/medicines6010031"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.lfs.2019.03.053","article-title":"Cannabidiol: Recent advances and new insights for neuropsychiatric disorders treatment","volume":"224","author":"Premoli","year":"2019","journal-title":"Life Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/head.13345","article-title":"Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science","volume":"58","author":"Baron","year":"2018","journal-title":"Headache"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00406-019-00978-2","article-title":"A randomised controlled trial of vaporised \u03949-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: Acute intoxication effects","volume":"269","author":"Solowij","year":"2019","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1017\/S1461145712001502","article-title":"The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: Involvement of the endocannabinoid system","volume":"16","author":"Campos","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"Ligresti","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"8711","DOI":"10.1074\/jbc.M114.618447","article-title":"Fatty acid-binding proteins (FABPs) are intracellular carriers for Delta9-tetrahydrocannabinol (THC) and cannabidiol (CBD)","volume":"290","author":"Elmes","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","article-title":"Targets of Cannabidiol in Neurological Disorders","volume":"12","author":"Chen","year":"2015","journal-title":"Neurotherapeutics"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41401-018-0031-9","article-title":"GPR3, GPR6, and GPR12 as novel molecular targets: Their biological functions and interaction with cannabidiol","volume":"40","author":"Laun","year":"2019","journal-title":"Acta. Pharmacol. Sin."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1089\/can.2018.0031","article-title":"Cannabidiol\u2019s Upregulation of N-acyl Ethanolamines in the Central Nervous System Requires N-acyl Phosphatidyl Ethanolamine-Specific Phospholipase D","volume":"3","author":"Leishman","year":"2018","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1124\/jpet.106.105247","article-title":"Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma","volume":"318","author":"Ligresti","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1152\/physrev.00002.2016","article-title":"From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology","volume":"96","author":"Ligresti","year":"2016","journal-title":"Physiol. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1017\/S1461145709990605","article-title":"A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL\/6JArc mice","volume":"13","author":"Long","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1111\/j.1476-5381.2011.01747.x","article-title":"Triphasic blood pressure responses to cannabinoids: Do we understand the mechanism?","volume":"165","author":"Malinowska","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/bph.14168","article-title":"Cannabinoids in arterial, pulmonary and portal hypertension\u2013Mechanisms of action and potential therapeutic significance","volume":"176","author":"Malinowska","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bph.12944","article-title":"Are cannabidiol and \u0394(9)-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review","volume":"172","author":"McPartland","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u0394(9)-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2125.2012.04351.x","article-title":"Is the cardiovascular system a therapeutic target for cannabidiol?","volume":"75","author":"Stanley","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fphar.2017.00081","article-title":"A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol","volume":"8","author":"Sultan","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Sultan, S.R., Millar, S.A., O\u2019Sullivan, S.E., and England, T.J. (2018). A Systematic Review and Meta-Analysis of the In Vivo Haemodynamic Effects of \u22069-Tetrahydrocannabinol. Pharmaceuticals, 11.","DOI":"10.3390\/ph11010013"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.lfs.2018.04.054","article-title":"Enhanced endocannabinoid tone as a potential target of pharmacotherapy","volume":"204","author":"Toczek","year":"2018","journal-title":"Life Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s40265-019-01171-4","article-title":"Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy","volume":"79","author":"Franco","year":"2019","journal-title":"Drugs"},{"key":"ref_29","unstructured":"(2020, May 18). Bedrocan (Producer of Legal Medicinal Cannabis) Website. Available online: https:\/\/bedrocan.com."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2017.02.041","article-title":"Cannabidiol: State of the art and new challenges for therapeutic applications","volume":"175","author":"Pisanti","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Atalay, S., Jarocka-Karpowicz, I., and Skrzydlewska, E. (2019). Antioxidative and Anti-Inflammatory Properties of Cannabidiol. Antioxidants, 9.","DOI":"10.3390\/antiox9010021"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Kis, B., Ifrim, F.C., Buda, V., Avram, S., Pavel, I.Z., Antal, D., Paunescu, V., Dehelean, C.A., Ardelean, F., and Diaconeasa, Z. (2019). Cannabidiol-from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20235905"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez, V., Iriondo De-Hond, A., Borrelli, F., Capasso, R., Del Castillo, M.D., and Abalo, R. (2020). Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093067"},{"key":"ref_34","unstructured":"(2020, May 18). Community Register of Orphan Medicinal Products (European Commision). Available online: https:\/\/ec.europa.eu\/health\/documents\/community-register\/html\/reg_od_act.htm?sort=a."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10286-017-0488-5","article-title":"The Endocannabinoid System in Cardiovascular Function: Novel Insights and Clinical Implications","volume":"28","author":"Sierra","year":"2018","journal-title":"Clin. Auton. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrcardio.2017.130","article-title":"Cardiovascular effects of marijuana and synthetic cannabinoids: The good, the bad, and the ugly","volume":"15","author":"Pacher","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1021\/ja01858a058","article-title":"Structure of cannabidiol, a product isolated from the marihuana extract of Minnesota wild hemp","volume":"62","author":"Adams","year":"1940","journal-title":"J. Am. Chem. Soc."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Jacob, A., and Todd, A.R. (1940). Cannabis indica. Part II. Isolation of cannabidiol from Egyptian hashish. Observations on the structure of cannabinol. J. Chem. Soc., 649\u2013653.","DOI":"10.1039\/jr9400000649"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/0040-4020(63)85022-X","article-title":"Hashish\u2013I. The structure of cannabidiol","volume":"19","author":"Mechoulam","year":"1963","journal-title":"Tetrahedron"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0040-4039(00)90646-4","article-title":"The absolute configuration of \u03941-tetra-hydrocannabinol, the major active constituent of hashish","volume":"12","author":"Mechoulam","year":"1967","journal-title":"Tetrahedron. Lett."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/tpj.14516","article-title":"Cannabis Glandular Trichomes Alter Morphology and Metabolite Content During Flower Maturation","volume":"101","author":"Livingston","year":"2020","journal-title":"Plant J."},{"key":"ref_42","unstructured":"Preedy, R.V. (2017). The Biosynthesis of Cannabinoids. Handbook of Cannabis and Related Pathologies, Elsevier. [1st ed.]."},{"key":"ref_43","first-page":"63","article-title":"Biosynthesis and biological functions of terpenoids in plants","volume":"148","author":"Tholl","year":"2015","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1089\/can.2016.0020","article-title":"Decarboxylation Study of Acidic Cannabinoids: A Novel Approach Using Ultra-High-Performance Supercritical Fluid Chromatography\/Photodiode Array-Mass Spectrometry","volume":"1","author":"Wang","year":"2016","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1476-5381.2010.01063.x","article-title":"Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action","volume":"162","author":"Maione","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1478-811X-8-12","article-title":"Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis","volume":"8","author":"Wolf","year":"2010","journal-title":"Cell Commun. Signal."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.phrs.2010.05.003","article-title":"Cannabidiol injected into the bed nucleus of the stria terminalis modulates baroreflex activity through 5-HT1A receptors","volume":"62","author":"Alves","year":"2010","journal-title":"Pharmacol. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/HJH.0000000000002333","article-title":"Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries-modification by hypertension and the potential pharmacological opportunities","volume":"38","author":"Kloza","year":"2020","journal-title":"J. Hypertens."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/1074248414532013","article-title":"The effect of cannabidiol on ischemia\/reperfusion-induced ventricular arrhythmias: The role of adenosine A1 receptors","volume":"20","author":"Gonca","year":"2015","journal-title":"J. Cardiovasc. Pharmacol Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/j.1471-4159.2007.04565.x","article-title":"Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor-independent myeloperoxidase-inhibiting mechanism","volume":"102","author":"Hayakawa","year":"2007","journal-title":"J. Neurochem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"14136","DOI":"10.1073\/pnas.96.24.14136","article-title":"Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors","volume":"96","author":"Wagner","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3389\/fphar.2019.00500","article-title":"Cannabidiol affects the Bezold-Jarisch reflex via TRPV1 and 5-HT3 receptors and his periperial sympathomimetic effects in spontaneously hypertensive and normotensive rats","volume":"10","author":"Kossakowski","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/01.STR.0000163083.59201.34","article-title":"Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine 1A receptor-dependent mechanism","volume":"36","author":"Mishima","year":"2005","journal-title":"Stroke"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neuropharm.2013.03.027","article-title":"Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: Role of 5HT(1A) and CB2 receptors","volume":"71","author":"Pazos","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1476-5381.2008.00046.x","article-title":"5-HT1A receptors are involved in the cannabidiol induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats","volume":"156","author":"Resstel","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/cvr\/cvv179","article-title":"Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation","volume":"107","author":"Stanley","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1124\/jpet.114.217125","article-title":"Cannabidiol improves vasorelaxation in Zucker diabetic fatty rats through cyclooxygenase activation","volume":"351","author":"Wheal","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3389\/fphar.2018.01365","article-title":"A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans","volume":"9","author":"Millar","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11419-007-0021-y","article-title":"Conversion of cannabidiol to D9-tetrahydrocannabinol and related cannabinoids in artificial gastric juice, and their pharmacological effects in mice","volume":"25","author":"Watanabe","year":"2007","journal-title":"Forensic Toxicol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1089\/can.2015.0004","article-title":"Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid","volume":"1","author":"Merrick","year":"2016","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/can.2016.0036","article-title":"Even High Doses of Oral Cannabidol Do Not Cause THC-Like Effects in Humans: Comment on Merrick et al. Cannabis and Cannabinoid Research 2016;1(1):102-112; doi:10.1089\/can.2015.0004","volume":"2","author":"Grotenhermen","year":"2017","journal-title":"Cannabis Cannabinoid. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/can.2017.0009","article-title":"A Conversion of Oral Cannabidiol to \u22069-Tetrahydrocannabinol Seems Not to Occur in Humans","volume":"2","author":"Nahler","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.euroneuro.2017.10.037","article-title":"Pharmacokinetic and behavioural profile of THC, CBD, and THC + CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC","volume":"27","author":"Uttl","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jpba.2017.11.054","article-title":"Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC\u2013MS\/MS) method for the determination of cannabidiol (CBD), \u03949-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD","volume":"150","author":"Palazzoli","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1089\/can.2017.0032","article-title":"Cannabidiol Does Not Convert to D9-Tetrahydrocannabinol in an In Vivo Animal Model","volume":"2","author":"Wray","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/epi.12631","article-title":"Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders","volume":"55","author":"Devinsky","year":"2014","journal-title":"Epilepsia"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1089\/can.2015.0012","article-title":"Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy","volume":"1","year":"2016","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.lfs.2011.05.018","article-title":"Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes","volume":"89","author":"Jiang","year":"2011","journal-title":"Life Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/can.2016.0034","article-title":"An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies","volume":"2","author":"Iffland","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ebcr.2017.10.001","article-title":"UAB CBD Program. An interaction between warfarin and cannabidiol, a case report","volume":"9","author":"Grayson","year":"2017","journal-title":"Epilepsy Behav. Case. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/bph.12560","article-title":"Vascular targets for cannabinoids: Animal and human studies","volume":"171","author":"Stanley","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3389\/fphys.2018.00622","article-title":"A Systematic Review of the Complex Effects of Cannabinoids on Cerebral and Peripheral Circulation in Animal Models","volume":"9","author":"Richter","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1111\/bph.12866","article-title":"Endothelial atypical cannabinoid receptor: Do we have enough evidence?","volume":"171","author":"Bondarenko","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1476-5381.1973.tb08262.x","article-title":"Cardiovascular and respiratory effects of cannabis in cat and rat","volume":"49","author":"Graham","year":"1973","journal-title":"Br. J. Pharmacol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00496070","article-title":"The effect of cannabidiol, alone and in combination with ethanol, on human performance","volume":"64","author":"Belgrave","year":"1979","journal-title":"Psychopharmacology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000137430","article-title":"Chronic administration of cannabidiol to healthy volunteers and epileptic patients","volume":"21","author":"Cunha","year":"1980","journal-title":"Pharmacology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00432554","article-title":"Action of cannabidiol on the anxiety and other effects produced by \u22069-THC in normal subjects","volume":"76","author":"Zuardi","year":"1982","journal-title":"Psychopharmacology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/clpt.1984.4","article-title":"Acute and subacute bronchial effects of oral cannabinoids","volume":"35","author":"Gong","year":"1984","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0091-3057(91)90386-G","article-title":"Controlled clinical trial of cannabidiol in Huntington\u2019s disease","volume":"40","author":"Consroe","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/026988119300700112","article-title":"Effects of ipsapirone and cannabidiol on human experimental anxiety","volume":"7","author":"Zuardi","year":"1993","journal-title":"J. Psychopharmacol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejphar.2004.03.045","article-title":"Cannabidiol lacks the vanilloid VR1-mediated vasorespiratory effects of capsaicin and anandamide in anaesthetised rats","volume":"491","author":"McQueen","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bbr.2006.05.016","article-title":"Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats","volume":"172","author":"Resstel","year":"2006","journal-title":"Behav. Brain. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.biopsych.2008.05.011","article-title":"Neural basis of \u0394-9-tetrahydrocannabinol and cannabidiol: Effects during response inhibition","volume":"64","author":"Borgwardt","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archgenpsychiatry.2009.17","article-title":"Modulation of mediotemporal and ventrostriatal function in humans by \u03949-tetrahydrocannabinol: A neural basis for the effects of Cannabis sativa on learning and psychosis","volume":"66","author":"Bhattacharyya","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archgenpsychiatry.2008.519","article-title":"Distinct effects of \u03949-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing","volume":"66","author":"Crippa","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/npp.2009.184","article-title":"Opposite effects of \u0394-9-tetrahydrocannainol and cannabidiol on human brain function and psychopathology","volume":"35","author":"Bhattacharyya","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.pbb.2011.06.027","article-title":"Effects of intracisternal administration of cannabidiol on the cardiovascular and behavioral responses to acute restraint stress","volume":"99","author":"Granjeiro","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.pnpbp.2010.11.002","article-title":"The interplay of cannabinoid and NMDA glutamate receptor systems in humans: Preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects","volume":"35","author":"Hallak","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/npp.2011.17","article-title":"Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: An FMRI study","volume":"36","author":"Allen","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0269881110389095","article-title":"Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors","volume":"26","author":"Gomes","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.2174\/138161212802884780","article-title":"Acute effects of a single, oral dose of d9- tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers","volume":"18","author":"Crippa","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.euroneuro.2012.09.007","article-title":"Cannabidiol administration into the bed nucleus of the stria terminalis alters cardiovascular responses induced by acute restraint stress through 5-HT\u2081A receptor","volume":"23","author":"Gomes","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1038\/npp.2015.367","article-title":"Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis","volume":"41","author":"Haney","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1007\/s12325-019-01074-6","article-title":"Examination of a New Delivery Approach for Oral Cannabidiol in Healthy Subjects: A Randomized, Double-Blinded, Placebo-Controlled Pharmacokinetics Study","volume":"36","author":"Patrician","year":"2019","journal-title":"Adv. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/da.23032","article-title":"Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: A human laboratory study","volume":"37","author":"Kayser","year":"2020","journal-title":"Depress. Anxiety"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Remiszewski, P., Jarocka-Karpowicz, I., Biernacki, M., Jastrz\u0105b, A., Schlicker, E., Toczek, M., Harasim-Symbor, E., P\u0119dzi\u0144ska-Betiuk, A., and Malinowska, B. (2020). Chronic Cannabidiol Administration Fails to Diminish Blood Pressure in Rats with Primary and Secondary Hypertension Despite Its Effects on Cardiac and Plasma Endocannabinoid System, Oxidative Stress and Lipid Metabolism. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21041295"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/bcp.14225","article-title":"The effects of acute and sustained cannabidiol dosing for seven days on the haemodynamics in healthy men: A randomised controlled trial","volume":"86","author":"Sultan","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/01.ijg.0000212260.04488.60","article-title":"Effect of sublingual application of cannabinoids on intraocular pressure: A pilot study","volume":"15","author":"Tomida","year":"2006","journal-title":"J. Glaucoma"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e93760","DOI":"10.1172\/jci.insight.93760","article-title":"A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study","volume":"2","author":"Jadoon","year":"2017","journal-title":"JCI Insight"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/00207458608985678","article-title":"Open label evaluation of cannabidiol in dystonic movement disorders","volume":"30","author":"Consroe","year":"1986","journal-title":"Int. J. Neurosci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.npp.1300340","article-title":"Effects of cannabidiol (CBD) on regional cerebral blood flow","volume":"29","author":"Crippa","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0041-008X(75)90275-6","article-title":"Cardiopulmonary effects of cannabidiol in anesthetized mongrel dogs","volume":"31","author":"Bright","year":"1975","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_103","first-page":"201","article-title":"Cannabidiol (CBD) attenuation of effects of \u22069-THC","volume":"15","author":"Borgen","year":"1973","journal-title":"Pharmacologist"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e00143","DOI":"10.1002\/prp2.143","article-title":"Pharmacological profiling of the hemodynamic effects of cannabinoid ligands: A combined in vitro and in vivo approach","volume":"3","author":"Walsh","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/j.1476-5381.2010.00755.x","article-title":"Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion","volume":"160","author":"Walsh","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2009.03.010","article-title":"Time-dependent vascular actions of cannabidiol in the rat aorta","volume":"612","author":"Sun","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"34595","DOI":"10.18632\/oncotarget.26191","article-title":"Up-regulation of heme oxygenase-1 expression and inhibition of disease-associated features by cannabidiol in vascular smooth muscle cells","volume":"9","author":"Schwartz","year":"2018","journal-title":"Oncotarget"},{"key":"ref_108","first-page":"659","article-title":"Effects of cannabinoids on the perfused rat heart","volume":"14","author":"Smiley","year":"1976","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ceca.2015.02.001","article-title":"Effects of cannabidiol on contractions and calcium signaling in rat ventricular myocytes","volume":"57","author":"Ali","year":"2015","journal-title":"Cell. Calcium."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3181\/00379727-180-42181","article-title":"Effects and interactions of natural cannabinoids on the isolated heart","volume":"180","author":"Nahas","year":"1985","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/clpt.2010.318","article-title":"Subjective and physiological effects after controlled Sativex and oral THC administration","volume":"89","author":"Karschner","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Biernacki, M., \u0141uczaj, W., Jarocka-Karpowicz, I., Ambro\u017cewicz, E., Toczek, M., and Skrzydlewska, E. (2018). The Effect of Long-Term Administration of Fatty Acid Amide Hydrolase Inhibitor URB597 on Oxidative Metabolism in the Heart of Rats with Primary and Secondary Hypertension. Molecules, 23.","DOI":"10.3390\/molecules23092350"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.prostaglandins.2018.09.001","article-title":"Hypertension and chronic inhibition of endocannabinoid degradation modify the endocannabinoid system and redox balance in rat heart and plasma","volume":"138","author":"Biernacki","year":"2018","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1152\/ajpheart.00098.2007","article-title":"Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury","volume":"293","author":"Durst","year":"2007","journal-title":"Am J. Physiol. Heart. Circ. Physiol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/FJC.0000000000000287","article-title":"Pharmacologic Effects of Cannabidiol on Acute Reperfused Myocardial Infarction in Rabbits: Evaluated with 3.0T Cardiac Magnetic Resonance Imaging and Histopathology","volume":"66","author":"Feng","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.etap.2013.04.018","article-title":"Cardioprotective effect of cannabidiol in rats exposed to doxorubicin toxicity","volume":"36","author":"Fouad","year":"2013","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2119\/molmed.2014.00261","article-title":"Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis","volume":"21","author":"Hao","year":"2015","journal-title":"Mol. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2119\/molmed.2016.00007","article-title":"Cannabidiol Limits T Cell-Mediated Chronic Autoimmune Myocarditis: Implications to Autoimmune Disorders and Organ Transplantation","volume":"22","author":"Lee","year":"2016","journal-title":"Mol. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1749-6632.2000.tb06193.x","article-title":"Neuroprotective antioxidants from marijuana","volume":"899","author":"Hampson","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.neuropharm.2008.06.040","article-title":"Cannabidiol prevents a post-ischemic injury progressively induced by cerebral ischemia via a high-mobility group box1-inhibiting mechanism","volume":"55","author":"Hayakawa","year":"2008","journal-title":"Neuropharmacology"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"139","DOI":"10.18869\/nirp.bcn.8.2.139","article-title":"Correlation Between Cannabidiol-Induced Reduction of Infarct Volume and Inflammatory Factors Expression in Ischemic Stroke Model","volume":"8","author":"Khaksar","year":"2017","journal-title":"Basic. Clin. Neurosci."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neuropharm.2016.12.017","article-title":"Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke","volume":"116","author":"Vargas","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1248\/bpb.32.1538","article-title":"Therapeutic time window of cannabidiol treatment on delayed ischemic damage via high-mobility group box1-inhibiting mechanism","volume":"32","author":"Hayakawa","year":"2009","journal-title":"Biol. Pharm. Bull."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(03)00569-X","article-title":"Post-ischemic treatment with cannabidiol prevents electroencephalographic flattening, hyperlocomotion and neuronal injury in gerbils","volume":"346","author":"Braida","year":"2003","journal-title":"Neurosci. Lett."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12640-014-9457-0","article-title":"Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice","volume":"26","author":"Schiavon","year":"2014","journal-title":"Neurotox. Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1203\/PDR.0b013e318186e5dd","article-title":"Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets","volume":"64","author":"Alvarez","year":"2008","journal-title":"Pediatr. Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1203\/PDR.0b013e3182276b11","article-title":"Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia-ischemia in newborn pigs","volume":"70","author":"Lafuente","year":"2011","journal-title":"Pediatr. Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fnins.2016.00323","article-title":"Effects of Cannabidiol and Hypothermia on Short-Term Brain Damage in New-Born Piglets after Acute Hypoxia-Ischemia","volume":"10","author":"Lafuente","year":"2016","journal-title":"Front. Neurosci."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/pr.2017.104","article-title":"Cannabidiol reduces lung injury induced by hypoxic-ischemic brain damage in newborn piglets","volume":"82","author":"Arruza","year":"2017","journal-title":"Pediatr. Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2018.11.020","article-title":"Neuroprotection by cannabidiol and hypothermia in a piglet model of newborn hypoxic-ischemic brain damage","volume":"146","author":"Barata","year":"2019","journal-title":"Neuropharmacology"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000471786","article-title":"High-Dose Cannabidiol Induced Hypotension after Global Hypoxia-Ischemia in Piglets","volume":"112","author":"Garberg","year":"2017","journal-title":"Neonatology"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1871527315666160927110305","article-title":"Neuroprotective Effects of Cannabidiol in Hypoxic Ischemic Insult. The Therapeutic Window in Newborn Mice","volume":"16","author":"Mohammed","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.neuropharm.2012.05.034","article-title":"Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function","volume":"63","author":"Pazos","year":"2012","journal-title":"Neuropharmacology"},{"key":"ref_135","first-page":"113","article-title":"Cannabidiol Administration Prevents Hypoxia-Ischemia-Induced Hypomyelination in Newborn Rats","volume":"10","author":"Vargas","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.nbd.2009.10.023","article-title":"The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors","volume":"37","author":"Castillo","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/pr.2016.149","article-title":"Short-term effects of cannabidiol after global hypoxia-ischemia in newborn piglets","volume":"80","author":"Garberg","year":"2016","journal-title":"Pediatr. Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-2094-8-5","article-title":"Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: An intravital microscopy study","volume":"8","author":"Benito","year":"2011","journal-title":"J. Neuroinflammation."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.lfs.2012.07.030","article-title":"Cannabidiol treatment ameliorates ischemia\/reperfusion renal injury in rats","volume":"91","author":"Fouad","year":"2012","journal-title":"Life Sci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejphar.2011.08.048","article-title":"Therapeutic potential of cannabidiol against ischemia\/reperfusion liver injury in rats","volume":"670","author":"Fouad","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.freeradbiomed.2011.02.021","article-title":"Cannabidiol protects against hepatic ischemia\/reperfusion injury by attenuating inflammatory signaling and response, oxidative\/nitrative stress, and cell death","volume":"50","author":"Mukhopadhyay","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2353\/ajpath.2006.050500","article-title":"Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes","volume":"168","author":"Khalifa","year":"2006","journal-title":"Am. J. Pathol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.jacc.2010.07.033","article-title":"Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy","volume":"56","author":"Rajesh","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fphar.2017.00248","article-title":"In Vivo Cannabidiol Treatment Improves Endothelium-Dependent Vasorelaxation in Mesenteric Arteries of Zucker Diabetic Fatty Rats","volume":"8","author":"Wheal","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2337\/dc16-0650","article-title":"Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study","volume":"39","author":"Jadoon","year":"2016","journal-title":"Diabetes Care"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"H610","DOI":"10.1152\/ajpheart.00236.2007","article-title":"Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption","volume":"293","author":"Rajesh","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejphar.2013.10.002","article-title":"Cannabinoids alter endothelial function in the Zucker rat model of type 2 diabetes","volume":"720","author":"Stanley","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1007\/BF01922330","article-title":"A cannabinoid with cardiovascular activity but no overt behavioral effects","volume":"33","author":"Adams","year":"1977","journal-title":"Experientia"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fphar.2017.00422","article-title":"An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol","volume":"8","author":"Morales","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.bjp.0707419","article-title":"The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects","volume":"152","author":"Johns","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/sj.bjp.0705160","article-title":"Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery","volume":"138","author":"Ho","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1124\/mol.63.3.699","article-title":"Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor","volume":"63","author":"Mo","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.phrs.2012.05.004","article-title":"Endothelium-dependent mechanisms of the vasodilatory effect of the endocannabinoid, anandamide, in the rat pulmonary artery","volume":"66","author":"MacLean","year":"2012","journal-title":"Pharmacol. Res."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejphar.2006.12.016","article-title":"2-Arachidonylglyceryl ether and abnormal cannabidiol-induced vascular smooth muscle relaxation in rabbit pulmonary arteries via receptor-pertussis toxin sensitive G proteins-ERK1\/2 signaling","volume":"559","author":"Su","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1097\/HJH.0b013e3282ef7a0a","article-title":"Identification of the vasodilatory endothelial cannabinoid receptor in the human pulmonary artery","volume":"25","author":"Baranowska","year":"2007","journal-title":"J. Hypertens."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/j.1476-5381.2012.02019.x","article-title":"GPR18 in microglia: Implications for the CNS and endocannabinoid system signalling","volume":"167","author":"McHugh","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.vph.2018.01.004","article-title":"The quest for endothelial atypical cannabinoid receptor: BKCa channels act as cellular sensors for cannabinoids in in vitro and in situ endothelial cells","volume":"102","author":"Bondarenko","year":"2018","journal-title":"Vascul. Pharmacol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1124\/jpet.113.209213","article-title":"The novel endocannabinoid receptor GPR18 is expressed in the rostral ventrolateral medulla and exerts tonic restraining influence on blood pressure","volume":"349","author":"Penumarti","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/FJC.0000000000000438","article-title":"The Effect of Chronic Activation of the Novel Endocannabinoid Receptor GPR18 on Myocardial Function and Blood Pressure in Conscious Rats","volume":"69","author":"Matouk","year":"2017","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejphar.2017.12.039","article-title":"Abnormal cannabidiol confers cardioprotection in diabetic rats independent of glycemic control","volume":"820","author":"Matouk","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/bph.12356","article-title":"Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice","volume":"170","author":"McKillop","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1007\/s00125-016-4108-z","article-title":"Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice","volume":"59","author":"McKillop","year":"2016","journal-title":"Diabetologia"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejphar.2019.04.050","article-title":"G-protein coupled receptor 55 agonists increase insulin secretion through inositol trisphosphate-mediated calcium release in pancreatic \u03b2-cells","volume":"85","author":"Vong","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.biopha.2018.12.126","article-title":"Novel protective effect of O-1602 and abnormal cannabidiol, GPR55 agonists, on ER stress-induced apoptosis in pancreatic \u03b2-cells","volume":"111","author":"Vong","year":"2019","journal-title":"Biomed. Pharmacother."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/18\/6740\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:09:52Z","timestamp":1760177392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/18\/6740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,14]]},"references-count":164,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["ijms21186740"],"URL":"https:\/\/doi.org\/10.3390\/ijms21186740","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,14]]}}}